IDS
Hunter Syndrome (MPS II): IDS Sequencing
Key Information
Lab:
TAT:
21 days
Price:
$1,000
CPT Code(s):
81405
Test Code:
DIDS
Prenatal Samples Accepted
Hunter Syndrome (MPS II): IDS Sequencing
IDS sequencing is a molecular test used to identify variants in the gene associated with Hunter syndrome (MPS II). This test can also be used to confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Hunter syndrome (MPS II)
Clinical Information
Hunter syndrome is an X-linked lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase. Features include coarse facial appearance, short stature, hepatosplenomegaly, intellectual disability and joint stiffness.
Technical Information
This test is performed by Sanger sequencing. IDS gene sequencing detects variants in approximately 82% of individuals with Hunter syndrome. Genomic DNA is used to amplify all 9 coding exons of the IDS gene by standard polymerase chain reaction. Each product is analyzed using a standard fluorescent sequencing protocol in both the forward and reverse orientations. If sequencing is normal, allele-specific PCR is used to detect a common inversion between intron 7 of the IDS gene and a region near exon 3 of IDS-2. If these two tests do not identify a causative change, testing will automatically reflex to IDS deletion/duplication analysis by MLPA at no additional charge.
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available for familial pathogenic or likely pathogenic variants; full sequencing of the IDS gene is not available. For variants identified at external laboratories, GGC will need to review the variant classification prior to sample receipt.
Prenatal diagnosis is not available for variants of uncertain clinical significance. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that targeted testing can be accepted.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Associated Tests
- Hunter Syndrome (MPS II): IDS Deletion/Duplication MLPA
- Hunter Syndrome (MPS II): Iduronate-2-Sulfatase Enzyme Analysis
- Hurler/Hunter Syndrome (MPS I/II): Urine Monitoring (Total GAGs, DS, HS)
- Maternal Cell Contamination
- Mucopolysaccharidosis (MPS) Enzyme Panel
- Mucopolysaccharidosis (MPS) Enzyme Panel (DBS)
- Mucopolysaccharidosis (MPS) Urine Analysis (Total GAGs, DS, CS, KS, HS)
- Targeted Analysis: Known Familial Variant
- Total Glycosaminoglycans (GAGs) Analysis
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
